tweak ep result
report solid result revenu ep come
estim consensu driven part strong perform humira
imbruvica base perform confid busi
manag rais ep target year follow quarter
tweak ep estim dcf-deriv pt remain
busi continu perform well took estim
maintain hold rate base view rel balanc
risk/reward stock
report ep estim consensu
revenu came model driven part higher sale
humira vs model imbruvica lower oper expens
partial off-set lower gross margin also contribut ep
upsid rel model
takeaway call
view key takeaway chang view
potenti eros humira due biosimilar competit europ
materi manag note would rais
guidanc concern recent fda comment interchang
chang compani view biosimilar risk us
alreadi assum long-rang plan would least one
interchang biosimilar year multipl year
pleas orilissa elagolix label allow flexibl dose
durat therapi continu believ drug sever bn peak
sale potenti manag note price orilissa way
discount lupron enhanc adopt
increas sale estim imbruvica lower estim
mavyret new revenu
revenu also rais sg estim
lower base compani revis spend target
chang took ep ep
price jul usd
valuat risk
pt base dcf
analysi impli stock
trade ep upsid
key product value-ad
news flow humira neg price
and/or volum impact recent
biosimilar launch humira slower
uptak imbruvica earlier-than-
expect gener competit key
failur disappoint capit
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar firm may conflict interest could affect object report investor
consid report singl factor make invest decis disclosur analyst
hold rate believ risk/reward stock
fairli balanc reflect reason posit outlook humira growth
durat well pipelin success solid medium-term growth
outlook robust cash gener strong dividend yield manag
focus sharehold return posit
target price base dcf analysi model sale
period determin termin valu base termin growth rate
assum termin growth given challeng forecast long-term cash
flow pharmaceut industri discount after-tax profit back
end believ approxim compani weight
averag cost capit target impli stock trade roughli
ep
upsid risk target price achiev includ higher-than-
expect sale key product greater pipelin success value-
news flow humira earlier-than-expect biosimilar competit
humira lower-than-expect sale humira imbruvica
product earlier-than-expect gener competit key product
greater price pressur delay get key pipelin candid market
includ elagolix risankizumab upadacitinib pipelin failur
disappoint capit deploy
expens changetot juli
expens changetot sell sell juli
juli
juli
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
look-up page websit
primari subject research pleas see recent publish compani report visit global disclosur
disclosur lookup legal tab investor strongli encourag review inform
invest
import disclosur requir regul
within
disclosur mark asterisk may also requir least one jurisdict addit unit state
import disclosur requir non-u regul explanatori note
deutsch bank and/or affili expect receiv intend seek compens invest bank
servic compani next three month
deutsch bank and/or affili receiv non-invest bank relat compens compani
within past year
compani client deutsch bank secur inc within past year time receiv
disclosur pertain recommend estim made secur primari subject
research pleas see recent publish compani report visit global disclosur look-up page
websit http //research db com/research/disclosures/compani riccod abbv
view express report accur reflect person view undersign lead analyst
subject issuer secur issuer addit undersign lead analyst receiv
compens provid specif recommend view report gregg gilbert
histor recommend target price abbv
septemb
analyst longer deutsch
upgrad hold target price chang
equiti rate dispers bank relationship
buy base current month view total
share-hold return tsr percentag chang
share price current price project target price
plu pro-ject dividend yield recommend
investor buy stock
sell base current view total share-
holder return recommend investor sell
hold take neutral view stock
base time horizon
recommend either buy sell
newli issu research recommend target
inform opinion report prepar deutsch bank ag one affili collect
deutsch bank though inform herein believ reliabl obtain public sourc
believ reliabl deutsch bank make represent accuraci complet hyperlink third-
parti websit report provid reader conveni deutsch bank neither endors content
use servic deutsch bank connect purchas sale secur discuss
report includ discuss anoth commun oral written deutsch bank analyst deutsch
deutsch bank may consid report decid trade princip may also engag transact
account custom manner inconsist view taken research report other within
deutsch bank includ strategist sale staff analyst may take view inconsist
taken research report deutsch bank issu varieti research product includ fundament analysi
equity-link analysi quantit analysi trade idea recommend contain one type commun
may differ recommend contain other whether result differ time horizon methodolog
perspect otherwis deutsch bank and/or affili may also hold debt equiti secur issuer
write analyst paid part base profit deutsch bank ag affili includ
opinion estim project constitut current judgment author date report
necessarili reflect opinion deutsch bank subject chang without notic deutsch bank provid
liquid buyer seller secur issu compani cover deutsch bank research analyst
sometim shorter-term trade idea may inconsist deutsch bank exist long-term rate
trade idea equiti list catalyst call research websit http //research db com/research/
found gener coverag list also cover compani page catalyst call repres
high-convict belief analyst stock outperform under-perform market and/or specifi sector
time frame less two week three month addit catalyst call analyst may
occasion discuss client deutsch bank salesperson trader trade strategi idea
refer catalyst event may near-term medium-term impact market price secur
discuss report impact may direct counter analyst current view total return
invest return describ herein deutsch bank oblig updat modifi amend report
otherwis notifi recipi thereof opinion forecast estim chang becom inaccur coverag
frequenc chang market condit gener company-specif econom prospect make
difficult updat research defin interv updat sole discret coverag analyst
research depart manag major report publish irregular interv report
provid inform purpos take account particular invest object financi
situat need individu client offer solicit offer buy sell financi
instrument particip particular trade strategi target price inher imprecis product
analyst judgment financi instrument discuss report may suitabl investor
investor must make inform invest decis price avail financi instrument
subject chang without notic invest transact lead loss result price fluctuat
factor financi instrument denomin currenc investor currenc chang
exchang rate may advers affect invest past perform necessarili indic futur result
perform calcul exclud transact cost unless otherwis indic unless otherwis indic price
current end previou trade session sourc local exchang via reuter bloomberg
vendor data
deutsch bank subject compani parti
deutsch research depart independ busi divis detail regard
organiz arrang inform barrier prevent avoid conflict interest respect
disclaim
also sourc
websit
macroeconom fluctuat often account risk associ exposur instrument promis
pay fix variabl interest rate investor long fixed-r instrument thu receiv cash
flow increas interest rate natur lift discount factor appli expect cash flow thu caus
loss longer matur certain cash flow higher move discount factor higher
loss upsid surpris inflat fiscal fund need fx depreci rate among common advers
macroeconom shock receiv counterparti exposur issuer creditworthi client segment regul
includ chang asset hold limit differ type investor chang tax polici currenc
convert may constrain currenc convers repatri profit and/or liquid posit
settlement issu relat local clear hous also import risk factor sensit fixed-incom
instrument macroeconom shock may mitig index contract cash flow inflat fx
depreci specifi interest rate common emerg market index fix may
construct lag mis-measur actual move underli variabl intend track choic
proper fix metric particularli import swap market float coupon rate coupon
index typic short-dat interest rate refer index exchang fix coupon fund currenc
differ currenc coupon denomin carri fx risk option swap swaption risk
deriv transact involv numer risk includ market counterparti default illiquid risk
appropri product use investor depend investor circumst includ tax
posit regulatori environ natur asset liabil investor take
expert legal financi advic enter transact similar inspir content
public risk loss futur trade option foreign domest substanti result
high degre leverag obtain futur option trade loss may incur greater
amount fund initi deposit theoret unlimit loss trade option involv risk
suitabl investor prior buy sell option investor must review characterist risk
standard option http //www optionsclear com/about/publications/character-risk jsp unabl
access websit pleas contact deutsch bank repres copi import document
particip foreign exchang transact may incur risk aris sever factor includ follow
exchang rate volatil subject larg fluctuat ii valu currenc may affect
numer market factor includ world nation econom polit regulatori event event equiti
debt market chang interest rate iii currenc may subject devalu government-impos
exchang control could affect valu currenc investor secur adr whose valu
affect currenc underli secur effect assum currenc risk
unless govern law provid otherwis transact execut deutsch bank entiti
investor home jurisdict asid within report import conflict disclosur also found
